Symbols

BEAM

Beam Therapeutics·NASDAQ

--(--)

BEAM fundamentals

BEAM Q4 2025 Earnings

Beam Therapeutics (BEAM) released its earnings on Feb 24, 2026: revenue was 114.11M (YoY +279.52%), beat estimates; EPS was 2.33 (YoY +313.76%), beat estimates.

Revenue / YoY

114.11M

+279.52%

EPS / YoY

2.33

+313.76%

Report date

Feb 24, 2026

BEAM Earnings Call Summary for Q4,2025

Breakthrough PKU Program: BEAM-304 targets two common mutations, with preclinical data showing rapid Phe normalization and potential to treat nearly half of PKU patients. FDA supports an adaptive clinical trial design for multiple mutations.
$500M Financing for Sickle Cell: Sixth Street funding extends Beam's runway to 2029, enabling risto-cel commercialization and pipeline advancement, including BEAM-302 and BEAM-304.
Platform Scalability: Base editing's modular design allows efficient mutation-specific therapy development, with LNP manufacturing consistency across programs.
Regulatory Innovation: FDA collaboration on umbrella trials and plausible mechanism pathways could accelerate approvals for ultra-rare diseases, informing PKU and other programs.

Earnings

EPS

Revenue

Revenue & Expenses

BEAM has released its 2025 Q4 earnings report, with revenue of 114.11M, reflecting a YoY change of 279.52%, and net profit of 244.30M, showing a YoY change of 370.38%. The Sankey diagram below clearly presents BEAM's revenue sources and cost distribution.

Key Indicators

Beam Therapeutics (BEAM) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Beam Therapeutics (BEAM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Beam Therapeutics (BEAM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Beam Therapeutics (BEAM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown